TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial.

Angharad G Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.